17 February 2021
Visiongain has published a new report on Wound Irrigation Systems Market Report 2021-2031: Forecasts by Type (Manually Operated & Battery Operated), Wound Type (Burns, Chronic Wounds (Surgical Wounds; Diabetic, Venous & Pressure Ulcers)), and End User (Hospitals, Ambulatory Surgical Centres). PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.
Global Wound Irrigation Systems market was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx billion by 2031.
Wound irrigation is the stable flow of a solution across an open wound surface to achieve wound hydration, to remove deeper fragments, and to support with the visual examination. The irrigation solution is meant to remove cellular debris and surface pathogens contained in wound exudates or residue from topically applied wound care products. Compared to sponging or bathing, wound irrigation is considered to be the most consistently effective method to wound cleansing.
The factor which are driving the growth of this market include an improving healthcare amenities, obtainability of advanced product lines for wound care management, surging occurrence rate of traumatic & surgical wounds, diabetic and pressure ulcers and continuing adoption of advanced wound care products are stimulating the growth of the global wound irrigation system market.
The global increase in the incidence of chronic diseases such as diabetes, cancer and other autoimmune diseases is anticipated to drive the market growth. Factors such as antimicrobial resistance, adoption of unhealthy and inactive lifestyles, alcohol consumption and smoking contribute to the rise in the prevalence of non-communicable diseases.
North America led the market in 2019. Growing cases of burns, the rising occurrence of chronic diseases, and the existence of numerous significant players are expected to drive the regional market. Also, the availability of skilled professionals and developed healthcare infrastructure are expected to drive the regional demand for wound irrigation systems.
The Asia Pacific region is expected to observe the rapid growth over the forecast period. The existence of emerging countries, such as China, India, and Japan is anticipated to boost growth. In addition, increasing occurrence of chronic wounds, especially diabetes is also expected to surge the regional market growth. According to the National Centre for Biotechnology Information (NCBI), around 1.77% of inpatients in China suffered from non-healing chronic ulcers in 2018.
Global Wound Irrigation Systems market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others to increase their footprints in this market. Some of the companies are mentioned- Zimmer Biomet, Stryker Corporation, Centurion Medical Products,Bsn Medical,Cooper Surgicals Inc, C,R. Bard Inc, Medtronic PLC, BionixWestmed Inc, Microaire Surgical Instruments.
Most key players are accepting various strategies, such as mergers and acquisitions, product launches, and partnerships to strengthen their position in the market.
For instance, in 2017, Bionix Inc. introduced the Igloo wound irrigation system. This system permits effective elimination of necrotic tissue and bacteria with continuous, high volume irrigation. This strategic inventiveness was estimated to expand the product range of the company, thus increasing its market share.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.
25 November 2022
Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.
25 November 2022
The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.
23 November 2022
The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.